Roche provides update on tominersen programme in manifest Huntington’s disease

NEXT STORY
Opiant Pharmaceuticals Strengthens Board of Directors With Appointment of Seasoned Clinical Development Executive Lorianne Masuoka, M.D.
PREV STORY
Tonix Pharmaceuticals Announces Results of Pre-IND Meeting with FDA on TNX-601 CR for the Treatment of Major Depressive Disorder
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Silo Wellness Commences Trading on the Canadian Securities Exchange Under Ticker Symbol “SILO”

author_avatar
NASDAQ Market News

Parexel Announces Acquisition of Leading Pharmacology Modeling & Analytics Modeling Firm Model Answers

author_avatar
NASDAQ Market News

Proactive news headlines including Royal Road Minerals, Great Panther Mining, PharmaDrug, Codebase Ventures and Nextech AR Solutions

author_avatar
NASDAQ Market News